Related Experiment Videos
[Digestive lymphosarcomas. Apropos of 30 cases]
La Semaine Des Hopitaux : Organe Fonde Par L'Association D'Enseignement Medical Des Hopitaux De Paris
|May 19, 1983
Summary
This study on digestive non-Hodgkin lymphomas found that intensive chemotherapy after surgery yields excellent remission rates. Lymphoblastic cases require more aggressive treatment for better outcomes.
Area of Science:
- Gastrointestinal Oncology
- Hematologic Malignancies
- Clinical Research
Context:
- Digestive non-Hodgkin lymphomas (NHL) present unique challenges in diagnosis and treatment.
- Tumor localization (gastric, ileocecal, small bowel) impacts patient demographics, with gastric involvement seen in older patients.
- Limited data exists on optimal management protocols for these specific NHL subtypes.
Purpose:
- To evaluate the efficacy of a specific intensive chemotherapy regimen combined with maximal surgery for digestive non-Hodgkin lymphomas.
- To analyze treatment outcomes based on tumor localization and lymphoma subtype.
- To identify factors influencing treatment failure and remission rates.
Summary:
- A study of 30 digestive non-Hodgkin lymphoma cases revealed gastric involvement in 14, ileocecal in 9, and small bowel in 7.
- Patients with gastric tumors were older (median 48.5 years) than others (median 26 years).
- Maximal surgery followed by adriamycin, VM 26, and cyclophosphamide chemotherapy resulted in 85% lasting complete remissions over a median 30-month follow-up.
Impact:
- The described chemotherapy protocol demonstrates high efficacy in achieving durable complete remissions for digestive non-Hodgkin lymphomas.
- Treatment failures were primarily observed in lymphoblastic cases, suggesting a need for intensified chemotherapy in this subgroup.
- This research provides valuable insights into optimizing treatment strategies for gastrointestinal lymphomas, potentially improving patient survival and quality of life.